Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Forming process method for high-strength functional PCL/HA porous bone scaffold

A molding process and functional technology, applied in the field of bone tissue engineering and repair of large bone defects, can solve the problems of insufficient scaffold strength, scaffold shrinkage and deformation, and great influence on scaffold forming accuracy, so as to achieve controllable release and accelerated Effects on bone repair and reconstruction

Active Publication Date: 2021-08-24
NORTHWESTERN POLYTECHNICAL UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But at the same time, the content of PCL has a great influence on the forming accuracy of the stent. Excessive PCL will lead to serious shrinkage and deformation of the stent. If it is too small, the strength of the stent will be insufficient, and the performance improvement will not be obvious.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Forming process method for high-strength functional PCL/HA porous bone scaffold
  • Forming process method for high-strength functional PCL/HA porous bone scaffold
  • Forming process method for high-strength functional PCL/HA porous bone scaffold

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031]In this embodiment, the high-strength PCL / HA antibacterial porous bone scaffold is compositely printed by hydroxyapatite, polycaprolactone, polymer binder and gentamicin. In terms of mass percentage, the content of hydroxyapatite is 90%, the content of polycaprolactone is 10%, the polymer binder is 0.8% PVA solution, and the drug content is negligible. The specification of the stent is a cylinder with a diameter of 2 cm, and the interior of the stent is filled with through macroscopic pores, and the cross-section of the pore is a square of 2 mm×2 mm.

[0032] Specific steps are as follows:

[0033] 1. Weigh hydroxyapatite and polycaprolactone powder according to the given content (90% HA content, 10% PCL content), and mix them in a spiral mixer for 2 hours;

[0034] 2. Soak the mixture powder obtained in step 1 in 75% ethanol solution for 24 hours to sterilize, then wash it repeatedly with sterile PBS buffer solution for 5 times, dry it at room temperature for 4 hours a...

Embodiment 2

[0040] In this embodiment, the high-strength PCL / HA antibacterial porous bone scaffold is compositely printed by hydroxyapatite, polycaprolactone, polymer binder and gentamicin. In terms of mass percentage, the content of hydroxyapatite is 70%, the content of polycaprolactone is 30%, the polymer binder is 0.8% PVA solution, and the drug content is negligible. The specification of the stent is a cylinder with a diameter of 2 cm, and the interior of the stent is filled with through macroscopic pores, and the cross-section of the pore is a square of 2 mm×2 mm.

[0041] Specific steps are as follows:

[0042] 1. Weigh the hydroxyapatite and polycaprolactone powder according to the given content (HA content 70%, PCL content 30%), and mix them in a spiral mixer for 2 hours;

[0043] 2. Soak the mixture powder obtained in step 1 in 75% ethanol solution for 24 hours to sterilize, then wash it repeatedly with sterile PBS buffer solution for 5 times, dry it at room temperature for 4 ho...

Embodiment 3

[0050] In this embodiment, the high-strength PCL / HA antibacterial porous bone scaffold is compositely printed by hydroxyapatite, polycaprolactone, polymer binder and gentamicin. In terms of mass percentage, the content of hydroxyapatite is 95%, the content of polycaprolactone is 5%, the polymer binder is 0.8% PVA solution, and the drug content is negligible. The specification of the stent is a cylinder with a diameter of 2 cm, and the interior of the stent is filled with through macroscopic pores, and the cross-section of the pore is a square of 2 mm×2 mm.

[0051] Specific steps are as follows:

[0052] 1. Weigh hydroxyapatite and polycaprolactone powder according to the given content (HA content 95%, PCL content 5%), and place them in a spiral mixer for 2 hours;

[0053] 2. Soak the mixture powder obtained in step 1 in 75% ethanol solution for 24 hours to sterilize, then wash it repeatedly with sterile PBS buffer solution for 5 times, dry it at room temperature for 4 hours ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
compressive strengthaaaaaaaaaa
particle diameteraaaaaaaaaa
compressive strengthaaaaaaaaaa
Login to View More

Abstract

The invention provides a forming process method for a high-strength functional PCL / HA porous bone scaffold. According to the forming process method, personalized manufacturing of the bone scaffold is realized by utilizing a 3DP process based on PCL / HA composite powder, and secondary curing of the bone scaffold is realized by utilizing secondary heating in combination with the characteristic of low melting point of PCL, so that the mechanical property of the scaffold is further improved; a high-energy post-treatment process is avoided while the strength of the scaffold is ensured so that functional substances can be synchronously compounded along with scaffold forming, and the functions of the scaffold are not influenced; by using the composite powder, the formed scaffold has high biological activity and high hardness endowed by HA, is beneficial to adhesion and proliferation of cells, and has high toughness and biodegradation characteristics endowed by PCL, so that stable transition between scaffold degradation and new bone formation is ensured, bone stability in the whole repair process is maintained, and enough redundancy is reserved for internal high porosity design; and in addition, the functional substances can be uniformly distributed on the whole scaffold instead of the surface of the scaffold, so that the prepared scaffold has better functions and bone repair and reconstruction effects.

Description

technical field [0001] The invention relates to the field of large-segment bone defect repair, in particular to a molding process method of a high-strength functional PCL / HA porous bone scaffold, belonging to the field of bone tissue engineering. Background technique [0002] Bone defects caused by trauma, tumors, etc. have always been the focus and difficulty of treatment. In clinical practice, autologous, allogeneic or xenogeneic bone grafts are usually used for repair. However, the source of autologous bone is insufficient, and there are many postoperative complications; the ability of allogeneic bone to combine with the host bone is weak, and it has antigenic properties, which may cause implantation failure due to severe immune rejection, and there is a possibility of disease transmission, and its clinical application is limited. . The development of bone tissue engineering provides a new solution, the core of which is to establish a space complex composed of cells / acti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): B29C64/165B29C64/393B29C64/379B29C64/295B29C64/314B33Y40/10B33Y30/00B33Y50/00B33Y40/20B33Y10/00C04B26/18C04B14/36C04B24/26
CPCB29C64/165B29C64/393B29C64/379B29C64/295B29C64/314B33Y40/10B33Y30/00B33Y50/00B33Y40/20B33Y10/00C04B26/18C04B2111/00181C04B14/366C04B24/2623
Inventor 魏庆华孙道岑汪焰恩卢婷利张映锋张卫红
Owner NORTHWESTERN POLYTECHNICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products